Vertex Pharmaceuticals Inc Cash Flow Reinvestment Rate
Vertex Pharmaceuticals Inc cash flow reinvestment rate. Vertex Pharmaceuticals Inc (VRTX) has a Cash Flow Reinvestment Rate of 0.16x as of June 2026, reinvesting $180.30 Million (capex $112.20 Million plus investments $68.10 Million) from operating cash flow of $1.13 Billion. See VRTX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Vertex Pharmaceuticals Inc (1993–2025)
Cash flow reinvestment rate of Vertex Pharmaceuticals Inc from 1993 to 2025. Historical reinvestment intensity for Vertex Pharmaceuticals Inc across 12 annual periods. Explore Vertex Pharmaceuticals Inc (VRTX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Vertex Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (1993–2025)
Vertex Pharmaceuticals Inc cash flow reinvestment rate by year from 1993 to 2025. Year-by-year capital reinvestment analysis for Vertex Pharmaceuticals Inc. For the full cash flow conversion analysis, see Vertex Pharmaceuticals Inc cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | $920.70 Million | $3.63 Billion | $437.60 Million | ▼ -61.6% |
| 2023 | 0.66x | $2.34 Billion | $3.54 Billion | $258.40 Million | ▲ +531.9% |
| 2022 | 0.10x | $432.00 Million | $4.13 Billion | $204.70 Million | ▲ +4.8% |
| 2021 | 0.10x | $263.90 Million | $2.64 Billion | $235.00 Million | ▼ -49.1% |
| 2020 | 0.20x | $638.31 Million | $3.25 Billion | $259.80 Million | ▲ +182.2% |
| 2019 | 0.07x | $109.11 Million | $1.57 Billion | $75.45 Million | ▼ -20.3% |
| 2018 | 0.09x | $110.87 Million | $1.27 Billion | $95.52 Million | ▼ -82.6% |
| 2017 | 0.50x | $422.79 Million | $844.94 Million | $259.42 Million | ▼ -33.4% |
| 2016 | 0.75x | $177.50 Million | $236.10 Million | $56.56 Million | ▼ -50.8% |
| 2012 | 1.53x | $409.04 Million | $267.84 Million | $71.14 Million | ▼ -43.6% |
| 2011 | 2.71x | $389.09 Million | $143.74 Million | $94.59 Million | ▲ +1193.3% |
| 1993 | 0.21x | $1.80 Million | $8.60 Million | $1.80 Million | — |